000 01633 a2200469 4500
005 20250515154641.0
264 0 _c20090407
008 200904s 0 0 eng d
022 _a1873-2399
024 7 _a10.1016/j.exphem.2008.11.004
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCrawford, Lisa J
245 0 0 _aProteasome proteolytic profile is linked to Bcr-Abl expression.
_h[electronic resource]
260 _bExperimental hematology
_cMar 2009
300 _a357-66 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aApoptosis
650 0 4 _aBenzamides
650 0 4 _aCell Transformation, Neoplastic
650 0 4 _aDrug Resistance, Neoplasm
650 0 4 _aFusion Proteins, bcr-abl
_xanalysis
650 0 4 _aGene Expression Regulation, Neoplastic
650 0 4 _aHumans
650 0 4 _aImatinib Mesylate
650 0 4 _aK562 Cells
650 0 4 _aLeukemia, Myelogenous, Chronic, BCR-ABL Positive
_xpathology
650 0 4 _aPiperazines
_xpharmacology
650 0 4 _aProtease Inhibitors
_xpharmacology
650 0 4 _aProteasome Endopeptidase Complex
_xmetabolism
650 0 4 _aPyrimidines
_xpharmacology
650 0 4 _aTumor Cells, Cultured
700 1 _aWindrum, Phlip
700 1 _aMagill, Laura
700 1 _aMelo, Junia V
700 1 _aMcCallum, Lynn
700 1 _aMcMullin, Mary F
700 1 _aOvaa, Huib
700 1 _aWalker, Brian
700 1 _aIrvine, Alexandra E
773 0 _tExperimental hematology
_gvol. 37
_gno. 3
_gp. 357-66
856 4 0 _uhttps://doi.org/10.1016/j.exphem.2008.11.004
_zAvailable from publisher's website
999 _c18604711
_d18604711